SV Health’s $269M de­men­tia fund; Schrödinger lays off 7% of staff

Plus, news about Beck­ley Psytech, Re­genxbio, Blue­print Med­i­cines, Van­tAI, Nov­elMed and Bay­er:

💰 SV Health clos­es sec­ond de­men­tia fund: The Lon­don-based biotech in­vest­ment firm …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

‭ Regulatory Lead / Head of Regulatory‬

Autonomy Bio Inc.

San Francisco, CA 94107, USA